0001062993-22-018004.txt : 20220815 0001062993-22-018004.hdr.sgml : 20220815 20220815170345 ACCESSION NUMBER: 0001062993-22-018004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220811 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker Matthew Allen CENTRAL INDEX KEY: 0001908721 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39894 FILM NUMBER: 221166535 MAIL ADDRESS: STREET 1: C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC STREET 2: 200 BOSTON AVENUE, SUITE 3100 CITY: MEDFORD STATE: MA ZIP: 02155 FORMER NAME: FORMER CONFORMED NAME: Walker Matthew Alan DATE OF NAME CHANGE: 20220202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC CENTRAL INDEX KEY: 0001822691 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851914700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BOSTON AVENUE STREET 2: SUITE 3100 CITY: MEDFORD STATE: MA ZIP: 02155 BUSINESS PHONE: (617) 616-8188 MAIL ADDRESS: STREET 1: 200 BOSTON AVENUE STREET 2: SUITE 3100 CITY: MEDFORD STATE: MA ZIP: 02155 FORMER COMPANY: FORMER CONFORMED NAME: Environmental Impact Acquisition Corp DATE OF NAME CHANGE: 20200826 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-08-11 0001822691 GreenLight Biosciences Holdings, PBC GRNA 0001908721 Walker Matthew Allen C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 1 0 1 0 Common Stock 2022-08-11 4 P 0 63775 3.92 A 63775 D Common Stock 2022-08-11 4 P 0 6377551 3.92 A 22220572 I by Builders Vision, LLC Consists of 63,775 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and Matthew Allen Walker. Includes 6,377,551 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and S2G Builders Food & Agriculture Fund III, LP ("Fund III"). Total number of shares beneficially owned by the Reporting Person includes: (i) 11,551,245 shares held by Fund III; (ii) 2,087,043 shares held by S2G Ventures Fund I, L.P. ("Fund I"); and (iiii) 8,582,284 shares held by S2G Ventures Fund II, L.P. ("Fund II" and, together with Fund I, and Fund III, the "S2G Funds"). Builders Vision, LLC is the Manager of Fund I and Fund II, and the General Partner of Fund III, and has power to vote or direct the voting of shares held by the S2G Funds. The General Partners of Fund I and Fund II are S2G Ventures, LLC and S2G Ventures II, LLC, respectively. (Continued) Mr. Walker, a director of the Issuer, is a Managing Director of Builders Vision, LLC, the impact platform founded by Lukas T. Walton, which includes S2G Ventures. By virtue of the foregoing, S2G Ventures, LLC and S2G Ventures II, LLC, Mr. Walker and Mr. Walton may be deemed to indirectly beneficially own (as defined in Rule 13d-3 of the Exchange Act) the shares of Common Stock held by the S2G Funds. Mr. Walker and Mr. Walton each disclaims beneficial ownership of these shares of Common Stock except to the extent of any pecuniary interest therein. /s/ David Kennedy, Attorney-in-fact for Matthew Allen Walker 2022-08-15